CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-07 | BARBERICH TIMOTHY J Director | Conversion · Series B Preferred Stock | +543,219 | 0 | ||
| 2019-10-07 | BARBERICH TIMOTHY J Director | Conversion · Series C Preferred Stock | +63,698 | 0 | ||
| 2019-10-07 | Loose Christopher R. Chief Scientific Officer | Conversion | +6,708 | 205,282 | ||
| 2019-10-07 | Loose Christopher R. Chief Scientific Officer | Conversion · Series A Preferred Stock | −45,182 | 0 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion | +352,509 | 352,509 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion | +617,916 | 956,175 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion · Series A Preferred Stock | −1,534,513 | 0 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion · Series B Preferred Stock | −839,816 | 0 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion · Series A Preferred Stock | −4,161,974 | 0 | ||
| 2019-10-07 | MARCUS JOEL S Director | Conversion · Series B Preferred Stock | −2,278,345 | 0 |
Page 34 of 34 · 670 trades